Consecutive patients meeting the inclusion criteria and treated as inpatients or treated in the anticoagulation bridging clinic at SHMC between January 1, 1999, and August 31, 2000, were selected for ...

Thromboembol in blood vessel. Clot formation, 3D illustration Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.

Please provide your email address to receive an email when new articles are posted on . Treatment of venous thromboembolism with oral apixaban was noninferior to subcutaneous dalteparin, without ...

The introduction of low-molecular-weight heparins (LMWHs) was a watershed event in the treatment of thrombotic disorders. LMWHs differ from unfractionated heparin (UFH) in that they have excellent ...